Address: General del Canto 421 – 6th Floor Providencia, Santiago de Chile
Tel: 5623275010
Web: http://www.boehringer-ingelheim.com/
Boehringer Ingelheim is a group of companies dedicated to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine. It is one of the world’s 20 leading pharmaceutical companies. In 2009 it had 142 affiliated companies in 47 countries employing 41,534 employees and with net sales of EUR 12,721 million.
The corporate vision of the company is given by one single phrase: ‘Value through Innovation’. The company was founded in Ingelheim am Rhein (Germany) in 1885, where the corporate headquarters is still located.
The business is divided into the following business areas: Human Pharmaceuticals, Prescription Medicines, Consumer Health Care, Industrial Customer, Biopharmaceuticals, Pharmaceuticals Production, Pharma Chemicals and Animal Health, the largest one being Prescription medicines, where 21% of the net sales is spent in R&D.
Boehringer Ingelheim Chile acts as a distributor of the company’s products in the local market. Supply for the Chilean market is provided by the company’s manufacturing plants in Brazil, Argentina, Colombia and Mexico. Nevertheless, Boehringer Ingelheim conducts several clinical trials in Chile.
Respiratory diseases, Cardiometabolic diseases, Oncology, Neurological diseases, Immunology, Infectious diseases
What have been Boehringer Ingelheim’s major milestones and achievements since your establishment in Chile? Chile, in the regional context, represents a very important market with a solid evolution in terms…
Eduardo Loyola has been at the helm of Heel’s Chilean affiliate for almost a decade. Prior to his appointment at Heel, Loyola was part of a working group that is…
Medtronic, world’s largest medical technology company, opened a direct operation in Chile in October 2013. Gonzalo Valdebenito elaborates on the affiliate’s first steps in the country and the mission he…
Cells for Cells is the first Chilean biotechnology company engaged in the research, development and commercialization of innovative cell therapies based on adult stem cells. In line with the company’s…
“We have implemented a strategic plan with a key objective to put Chile on the map. We are seeing major market opportunities in the country”, says Carlos Cicogna, Managing Director,…
Ciro Caravaggio, General Manager at Roche Chile discusses Roche’s mission as a highly specialized biotech with a long presence in Chile. He stresses the importance of the affiliate’s role in…
Raúl Sánchez, general manager of Peri Logistics speaks about the main features that distinguish Peri Logistics as a pharmaceutical logistics operator. Celebrating its 10th year anniversary this year, the company…
João Simões, Head of Integration at Grunenthal Chile, discusses Grunenthal’s acquisition of Andrómaco Laboratories. The acquisition has been a major step in Grunenthal’s growth strategy and has almost doubled its…
“70 percent of products on the Chilean market cannot demonstrate quality, safety and efficacy through bioequivalence studies”, explains Jean Jacques Duhart, Vicepresidente Ejecutivo of the association that represents the innovative…
Rodrigo Azócar Ibaceta, general manager at Laboratorios Raffo Chile speaks about Raffo’s development on the Chilean market. Part of the prestigious GP Pharm’s group, Raffo is one of the fastest…
Erich Viertel Molina, country manager at Janssen Chile speaks about Janssen’s commitment to the health of Chileans. Over the past years Janssen successfully launched several products to the Chilean market…
Pfizer will invest in a precision medical center studying new genome-based diagnostic technologies for cancer in Chile. It is the first center of excellence that Pfizer is building in Chile…
Our business model is new in the Chilean market and enables us with great flexibility and allows us to focus on demand generation. For Ferrer this is a great window…
See our Cookie Privacy Policy Here
